FDA Approved: VOYDEYA — Supplemental Application (Alexion Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for VOYDEYA (danicopan) by Alexion Pharmaceuticals to treat paroxysmal nocturnal hemoglobinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• VOYDEYA (DANICOPAN)

Snippet

SUPPL AP for VOYDEYA (DANICOPAN)